Company News in the Life Science Industry

»

Reset 

Humanigen Secures Exclusive Worldwide License for the Prevention of GvHD through GM-CSF Neutralization from the University of Zurich

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Humanigen, Inc

Salarius Pharmaceuticals Announces Closing of Strategic Merger with Flex Pharma

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Salarius Pharmaceuticals, LLC

Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Delcath Systems Inc.

Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Adaptimmune Therapeutics plc.

Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Salarius Pharmaceuticals, LLC

BioCorRx Announces the Launch of UnCraveRx On-Demand Virtual Fitness, Lifestyle Support and Nutrition App

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  BioCorRx, Inc.

Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Therapeutic Solutions International, Inc.

Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Obalon Therapeutics Inc.

Turning Point Therapeutics to Host Second Quarter 2019 Conference Call

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Turning Point Therapeutics, Inc.

Naboso™ Technology Announces Partnership with Xero Shoes, Bringing First Barefoot Proprioceptive Sandals to Market

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019

Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Innovation Pharmaceuticals Inc.

Bhang CBD Products Now Available in Cannabis Now’s Flagship Beverly Hills Location

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019

Global Expansion Efforts Begin Yielding Results

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Precipio Diagnostics

Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Genmab A/S

ASIT biotech Raises EUR 9.225 Million in a Private Placement of Convertible Notes

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  ASIT Biotech S.A.

Transactions in relation to share buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Össur Nordic AB | Össur Germany GmbH | Össur Americas, Inc.

Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Endonovo Therapeutics, Inc.

ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Hepion Pharmaceuticals, Inc.

BioCorRx’s Director Louis Lucido Appeared Today on Yahoo Finance LIVE “On the Move”

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  BioCorRx, Inc.

HAMLET Pharma Announces Results of First Major Clinical Trial for a New Cancer Killing Molecule

LUND, Sweden, July 22, 2019 /PRNewswire/ -- A research group in Lund led by Professor Catharina Svanborg discovered in 1995 that a component of human breast milk kills tumor cells without harming mature, healthy cells. Further experiments and studies have shown that the effect is due to the most... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  Hamlet Pharma AB
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies